rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Eric G. Carter

Director

Company insider

Files Form 4 as: Director, AEON Biopharma; Director, Adverum Biotechnologies; Interim Chief Medical Officer, Alder Biopharmaceuticals; Chief Science Officer, King Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
50
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
4
Companies where not an officer
2
First trade
24 Jan 2007
Last trade
17 Jun 2026
Last filed
22 Jun 2026

Companies traded

Where they are an officer
Alder BiopharmaceuticalsOfficer · last 23 Apr 20180 buys · 0 sells
King PharmaceuticalsOfficer · last 31 Jan 20110 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
AEON AEON BiopharmaDirector · Biotechnology · last 17 Jun 20260 buys · 0 sells
Adverum BiotechnologiesDirector · last 23 Jun 20200 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
17 Jun 2026filed 22 Jun 2026AEON AEON BiopharmaBiotechnologySEC FORM 4 Code A—222,684 at $0.00filing
17 Jun 2026filed 22 Jun 2026AEON AEON BiopharmaBiotechnologySEC FORM 4 Code A—222,684 at $0.00filing
21 May 2025filed 23 May 2025AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—308,641 at $0.00filing
31 Aug 2024filed 4 Sep 2024AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—96,210 at $0.00filing
31 Aug 2024filed 4 Sep 2024AEON AEON BiopharmaBiotechnologySEC FORM 4 Code A—36,021 at $0.00filing
19 Mar 2024filed 21 Mar 2024AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—16,260 at $0.00filing
19 Mar 2024filed 21 Mar 2024AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—8,130 at $0.00filing
14 Aug 2023filed 16 Aug 2023AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—58,851 at $0.00filing
21 Jul 2023filed 24 Jul 2023AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—9,007 at $0.00filing
21 Jul 2023filed 24 Jul 2023AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—11,802 at $0.00filing
23 Jun 2020filed 25 Jun 2020Adverum Biotechnologiesoption or derivativeSEC FORM 4 Code A—30,000 at $0.00filing
31 Jul 2019filed 2 Aug 2019Adverum Biotechnologiesoption or derivativeSEC FORM 4 Code A—45,000 at $0.00filing
31 May 2018filed 15 Jun 2018Adverum Biotechnologiesoption or derivativeSEC FORM 4 Code A—35,000 at $0.00filing
23 Apr 2018filed 25 Apr 2018Alder Biopharmaceuticalsoption or derivativeSEC FORM 4 Code A—75,000 at $0.00filing
7 Sep 2017filed 8 Sep 2017Adverum BiotechnologiesSEC FORM 4 Code A—48,000 at $0.00filing
7 Sep 2017filed 8 Sep 2017Adverum Biotechnologiesoption or derivativeSEC FORM 4 Code A—69,000 at $0.00filing
31 Jan 2011filed 2 Feb 2011King Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—55,740filing
31 Jan 2011filed 2 Feb 2011King Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—17,860filing
31 Jan 2011filed 2 Feb 2011King Pharmaceuticalsoption or derivativeSEC FORM 4 Code J—34,240filing
31 Jan 2011filed 2 Feb 2011King Pharmaceuticalsoption or derivativeSEC FORM 4 Code J—50,290filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Nobody else traded the same names lately.